JPRN-UMIN000038389尚未招募未知
Survey on polyphenol intake: an open survey - Survey on polyphenol intake: an open survey
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 64
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 30years-old 至 70years-old(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) Subjects who have serious complication or suffer from urgent need of medical treatment (2) Subjects who can't stop using medicines, supplements and/or functional foods (including Food for Specified Health Uses or Foods with Function Claims) that may affect the investigation during the survey periods (3) Subjects who have a history of and/or contract drug addiction and/or alcoholism (4) Subjects who have meals less than twice a day (5) Subjects who work night shifts or shift workers (6) Subjects who have abnormality in renal function (7) Subjects who repeats cystitis frequently (8) Subjects whose menstruation is predicted during the test periods (9) Subjects who have a history and/or a surgical history of digestive disease affecting digestion and absorption (10) Subjects who have a history of and/or contract serious diseases (eg, heart disease, liver disease, endocrine disease, thyroid disease, adrenal disease and/or metabolic disease) (11) Subjects who are pregnant, lactation, or planning to become pregnant (12) Subjects who are planning to participate and/or participate in other clinical studies (13) Subjects who are judged as unsuitable for the current study by the investigator for other reasons
研究者
相似试验
已完成
不适用
An open-label study to assess the absorption, distribution, metabolism and excretion, including the mass balance of [14C] labeled BIA 5-1058 and metabolites following a single oral dose administration in healthy male subjects<br>cardiovascular diseases1008220610047066NL-OMON45578Bial Portela & Ca.8
已完成
不适用
An Open-Label Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-JNJ-67856633, a MALT1 inhibitor, After a Single Oral Dose in Healthy Male Participantschronic lymphocytic leukemiablood cancersLymphomas10025320NL-OMON50324Janssen-Cilag8
已完成
不适用
Whether Anti-diabetic drugs can be used with Ayurvedic herbs?CTRI/2018/01/011632All India Institute of Ayurveda250
进行中(未招募)
1 期
A study to explore how the inhaled CHF 5993 (triple fixed combination) penetrates lungs using imaging techniqueEUCTR2017-000438-79-BEChiesi Farmaceutici S.p.A.30
进行中(未招募)
1 期
A study to explore how the inhaled CHF 5993 (triple fixed combination) penetrates lungs using imaging techniqueCOPDMedDRA version: 20.0 Level: LLT Classification code 10010952 Term: COPD System Organ Class: 100000015472EUCTR2017-000438-79-HUChiesi Farmaceutici S.p.A.30
